Clinical Trial Update: A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating BL-M07D1 versus pembrolizumab plus platinum-based chemotherapy as first-line treatment for HER2-mutant advanced or metastatic non-squam…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BL-M07D1
• Pembrolizumab (pembrolizumab)
• Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Non-squamous Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING